Cardiac: Page 2

  • Two clinicians wearing scrubs stand in front of Intuitive Surgical's da Vinci 5 robotic surgery system.
    Image attribution tooltip
    Courtesy of Tampa General Hospital
    Image attribution tooltip

    Intuitive’s cardiac initiative includes valve repair, LAA closure

    With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.

    By • Jan. 26, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • An artificial heart valve is pictured against a white background.
    Image attribution tooltip
    Retrieved from Anteris Technologies Global on January 21, 2026
    Image attribution tooltip

    Medtronic to buy up to $90M stake in heart valve developer Anteris

    Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

    By • Jan. 21, 2026
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott gets Europe’s CE mark for dual ablation catheter

    The device can deliver both radiofrequency energy and pulsed field ablation to treat heart arrhythmias.

    By • Jan. 20, 2026
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to acquire Penumbra for $14.5B

    With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

    By • Jan. 15, 2026
  • Boston Scientific's Farapoint pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific gains FDA’s OK for new PFA catheter

    The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.

    By • Jan. 14, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards calls off JenaValve buyout after court halts deal

    Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns.

    By • Jan. 12, 2026
  • A person walks toward a door while carrying a briefcase.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Teleflex CEO leaving company

    Stuart Randle, who retired in 2018, has replaced Liam Kelly as CEO and president on an interim basis.

    By • Jan. 9, 2026
  • Stereotaxis' GenesisX surgical robot is shown against a white background.
    Image attribution tooltip
    Permission granted by Stereotaxis
    Image attribution tooltip

    Stereotaxis wins FDA approval for robotically navigated ablation catheter

    Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a J&J catheter.

    By • Jan. 7, 2026
  • A 3D visualization of red blood cells traveling through a blood vessel.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Biobeat raises $50M to commercialize cuffless blood pressure monitor

    The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.

    By • Jan. 6, 2026
  • Close up of a white cylindrical device.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards receives FDA approval for mitral valve replacement system

    The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

    By • Dec. 23, 2025
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts Class I recall notice about Medtronic heart vent catheters

    The company received three complaints about patients who had perforation injuries linked to the devices.

    By • Dec. 23, 2025
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott receives FDA approval for Volt PFA system

    Abbott can now compete with Medtronic, Boston Scientific and J&J in the U.S. for the fast-growing pulsed field ablation market.

    By • Dec. 22, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott receives clearance for heart delivery device in premature babies

    Physician feedback has informed a delivery device designed to make procedures safer and easier.

    By • Dec. 22, 2025
  • FDA sign
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pulse Biosciences wins FDA approval to begin PFA catheter study

    Shorter, nanosecond pulses for treating atrial fibrillation differentiate the company’s approach from existing pulsed field ablation systems on the market.

    By • Dec. 18, 2025
  • Edwards Lifesciences' Sapien 3 Ultra heart valve replacement system is shown with the valve expanded by a balloon.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    CMS considers expanding TAVR coverage to asymptomatic patients

    Medicare reimbursement for aortic stenosis patients without symptoms could accelerate procedure growth for Edwards Lifesciences, which requested the CMS review, analysts said.

    By • Dec. 16, 2025
  • A person wearing scrubs, a mask and a cap looks at a screen with images.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips to acquire SpectraWAVE

    SpectraWAVE makes technologies to help diagnose and guide treatment decisions for coronary artery disease.

    By • Dec. 15, 2025
  • AtriCure’s EnCompass Clamp device is shown against a white background.
    Image attribution tooltip
    Retrieved from AtriCure on December 12, 2025
    Image attribution tooltip

    AtriCure treats first patients with dual PFA/RF system

    Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

    By • Dec. 12, 2025
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Impulse Dynamics raises $158M to commercialize heart failure device

    By strengthening heart contractions, Impulse’s device could improve quality of life, restore functional capacity and enhance tolerance for exercise. 

    By • Dec. 11, 2025
  • A sign for the FDA is shown in front of the headquarters building in Silver Spring, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA pilots allowing digital health devices access to CMS payment program

    Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect real-world data in a CMS program.

    By • Dec. 10, 2025
  • V-Wave's implantable device for heart failure is shown next to a dime.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    FDA advisory panel votes unanimously against J&J heart shunt

    Panelists focused on study data that showed the implant did not improve outcomes in heart failure patients.

    By • Dec. 5, 2025
  • A warehouse with rows of packages
    Image attribution tooltip
    Courtesy of Medline
    Image attribution tooltip

    PitchBook: AI tuck-in deals to drive M&A acceleration in 2026

    Buyers will focus on “tuck-ins that add AI or data-driven capabilities or can meaningfully improve scale against emerging competitors,” the analysts said.

    By • Dec. 3, 2025
  • Boston Scientific's Farawave pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    CMS covers cardiac ablation in ambulatory surgery centers

    Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.

    By • Nov. 26, 2025
  • A 3D visualization of red blood cells traveling through a blood vessel.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Okami raises $45M to commercialize vascular embolization devices

    The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

    By • Nov. 24, 2025
  • Nick West, chief medical officer of J&J unit Shockwave, smiles in a headshot.
    Image attribution tooltip
    Permission granted by J&J MedTech
    Image attribution tooltip
    Q&A

    Shockwave’s Nick West on shaking up treatment for blocked arteries

    The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.

    By • Nov. 21, 2025